Guidance on the Appropriate Use of Monoclonal Antibodies

Despite the proven usefulness of monoclonal antibodies (mAbs) in protecting residents from poor COVID-19 outcomes and the potential they offer for preventing risky hospital transfers, many long-term care clinicians remain unfamiliar with mAbs clinical protocols or unprepared to place orders.

Download this tip sheet outlining a decision process to determine whether mAbs should be ordered for residents diagnosed with COVID-19.